Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Is There a Spillover Effect of Targeted Dietary Change on Untargeted Health Behaviors? Evidence From a Dietary Modification Trial.

Sarma EA, Moyer A, Messina CR, Laroche HH, Snetselaar L, Van Horn L, Lane DS.

Health Educ Behav. 2019 Aug;46(4):569-581. doi: 10.1177/1090198119831756. Epub 2019 Feb 27.

PMID:
30808245
2.

The Emerging Identity of the Preventive Medicine Specialty: A Model for the Population Health Transition.

Jadotte YT, Leisy HB, Noel K, Lane DS.

Am J Prev Med. 2019 Apr;56(4):614-621. doi: 10.1016/j.amepre.2018.10.031. Epub 2019 Feb 16. No abstract available.

PMID:
30782402
3.

Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis.

Carr PR, Banbury BL, Berndt SI, Campbell PT, Chang-Claude J, Hayes RB, Howard BV, Jansen L, Jacobs EJ, Lane DS, Nishihara R, Ogino S, Phipps AI, Slattery ML, Stefanick ML, Wallace R, Walter V, White E, Wu K, Peters U, Chan AT, Newcomb PA, Brenner H, Hoffmeister M.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1561-1570.e3. doi: 10.1016/j.cgh.2018.11.036. Epub 2018 Nov 23.

PMID:
30476588
4.

In consensus we trust? Persuasive effects of scientific consensus communication.

Chinn S, Lane DS, Hart PS.

Public Underst Sci. 2018 Oct;27(7):807-823. doi: 10.1177/0963662518791094. Epub 2018 Jul 30. Erratum in: Public Underst Sci. 2019 Jul;28(5):630.

PMID:
30058947
5.

Changes in Overall Diet Quality in Relation to Survival in Postmenopausal Women with Breast Cancer: Results from the Women's Health Initiative.

Sun Y, Bao W, Liu B, Caan BJ, Lane DS, Millen AE, Simon MS, Thomson CA, Tinker LF, Van Horn LV, Vitolins MZ, Snetselaar LG.

J Acad Nutr Diet. 2018 Oct;118(10):1855-1863.e6. doi: 10.1016/j.jand.2018.03.017. Epub 2018 May 30.

PMID:
29859758
6.

Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.

Kabat GC, Kim MY, Stefanick M, Ho GYF, Lane DS, Odegaard AO, Simon MS, Bea JW, Luo J, Wassertheil-Smoller S, Rohan TE.

Int J Cancer. 2018 Aug 1;143(3):543-551. doi: 10.1002/ijc.31345. Epub 2018 Mar 14.

PMID:
29488210
7.

Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.

Kabat GC, Kim MY, Lane DS, Zaslavsky O, Ho GYF, Luo J, Nicholson WK, Chlebowski RT, Barrington WE, Vitolins MZ, Lin X, Liu S, Rohan TE.

Eur J Cancer Prev. 2018 May;27(3):261-268. doi: 10.1097/CEJ.0000000000000435.

PMID:
29438162
8.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.

Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, Shifren J, Chen C, Kaunitz AM, Cauley JA, Manson JE.

Menopause. 2018 Jan;25(1):11-20. doi: 10.1097/GME.0000000000000956.

9.

Do they practice what we preach: Findings from over a decade of breast imaging CME.

Kirschen GW, Lane DS, Messina CR, Fisher PR.

Breast J. 2018 Jan;24(1):101-102. doi: 10.1111/tbj.12845. Epub 2017 Jun 6. No abstract available.

PMID:
28585709
10.

Changes in the Inflammatory Potential of Diet Over Time and Risk of Colorectal Cancer in Postmenopausal Women.

Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Lane DS, Ho GYF, Hou L, Snetselaar L, Ockene JK, Hebert JR.

Am J Epidemiol. 2017 Sep 1;186(5):514-523. doi: 10.1093/aje/kwx115.

11.

Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.

Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Zeng D, Kim E, Yaffe MD, Boyd NF, Heiss G, McTiernan A, Chlebowski RT, Lane DS, Manson JE, Wactawski-Wende J, Pisano ED.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx001.

12.

Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.

Jung SY, Barrington WE, Lane DS, Chen C, Chlebowski R, Corbie-Smith G, Hou L, Zhang ZF, Paek MS, Crandall CJ.

Menopause. 2017 Mar;24(3):288-298. doi: 10.1097/GME.0000000000000753.

13.

Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.

Kabat GC, Wu WY, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Lane DS, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE.

Int J Obes (Lond). 2017 Jan;41(1):170-177. doi: 10.1038/ijo.2016.179. Epub 2016 Oct 17.

PMID:
27748744
14.

Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States.

Arnold M, Jiang L, Stefanick ML, Johnson KC, Lane DS, LeBlanc ES, Prentice R, Rohan TE, Snively BM, Vitolins M, Zaslavsky O, Soerjomataram I, Anton-Culver H.

PLoS Med. 2016 Aug 16;13(8):e1002081. doi: 10.1371/journal.pmed.1002081. eCollection 2016 Aug.

15.

Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal women.

Tabung FK, Steck SE, Liese AD, Zhang J, Ma Y, Johnson KC, Lane DS, Qi L, Snetselaar L, Vitolins MZ, Ockene JK, Hebert JR.

Breast Cancer Res Treat. 2016 Aug;159(1):139-49. doi: 10.1007/s10549-016-3925-6. Epub 2016 Jul 30.

16.

Coffee Consumption and the Incidence of Colorectal Cancer in Women.

Groessl EJ, Allison MA, Larson JC, Ho SB, Snetslaar LG, Lane DS, Tharp KM, Stefanick ML.

J Cancer Epidemiol. 2016;2016:6918431. doi: 10.1155/2016/6918431. Epub 2016 Apr 28.

17.

Longitudinal association of hemostatic factors with risk for cancers of the breast, colorectum, and lung among postmenopausal women.

Kabat GC, Salazar CR, Zaslavsky O, Lane DS, Rohan TE.

Eur J Cancer Prev. 2016 Sep;25(5):449-56. doi: 10.1097/CEJ.0000000000000193.

PMID:
26317383
18.

Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study.

Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng TY, Miller JW, Green R, Lane DS, Beresford SA, Caudill MA.

Cancer Res. 2014 Dec 15;74(24):7442-52. doi: 10.1158/0008-5472.CAN-14-1835. Epub 2014 Oct 21.

19.

Mammography interval and breast cancer mortality in women over the age of 75.

Simon MS, Wassertheil-Smoller S, Thomson CA, Ray RM, Hubbell FA, Lessin L, Lane DS, Kuller LH.

Breast Cancer Res Treat. 2014 Nov;148(1):187-95. doi: 10.1007/s10549-014-3114-4. Epub 2014 Sep 25.

20.

Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial.

Thomson CA, Van Horn L, Caan BJ, Aragaki AK, Chlebowski RT, Manson JE, Rohan TE, Tinker LF, Kuller LH, Hou L, Lane DS, Johnson KC, Vitolins MZ, Prentice RL.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2924-35. doi: 10.1158/1055-9965.EPI-14-0922. Epub 2014 Sep 25.

21.

Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.

Kabat GC, Kamensky V, Heo M, Bea JW, Hou L, Lane DS, Liu S, Qi L, Simon MS, Wactawski-Wende J, Rohan TE.

Maturitas. 2014 Sep;79(1):70-6. doi: 10.1016/j.maturitas.2014.06.006. Epub 2014 Jun 16.

PMID:
25011395
22.

Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.

Zhao S, Chlebowski RT, Anderson GL, Kuller LH, Manson JE, Gass M, Patterson R, Rohan TE, Lane DS, Beresford SA, Lavasani S, Rossouw JE, Prentice RL.

Breast Cancer Res. 2014 Mar 26;16(2):R30. doi: 10.1186/bcr3632.

23.

Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.

Brasky TM, Liu J, White E, Peters U, Potter JD, Walter RB, Baik CS, Lane DS, Manson JE, Vitolins MZ, Allison MA, Tang JY, Wactawski-Wende J.

Int J Cancer. 2014 Oct 15;135(8):1869-83. doi: 10.1002/ijc.28823. Epub 2014 Mar 20.

24.

Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative.

Thomson CA, McCullough ML, Wertheim BC, Chlebowski RT, Martinez ME, Stefanick ML, Rohan TE, Manson JE, Tindle HA, Ockene J, Vitolins MZ, Wactawski-Wende J, Sarto GE, Lane DS, Neuhouser ML.

Cancer Prev Res (Phila). 2014 Jan;7(1):42-53. doi: 10.1158/1940-6207.CAPR-13-0258.

25.

Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative.

Wassertheil-Smoller S, McGinn AP, Budrys N, Chlebowski R, Ho GY, Johnson KC, Lane DS, Li W, Neuhouser ML, Saquib J, Shikany JM, Song Y, Thomson C.

Breast Cancer Res Treat. 2013 Oct;141(3):495-505. doi: 10.1007/s10549-013-2712-x. Epub 2013 Oct 9.

26.

Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Farhat GN, Parimi N, Chlebowski RT, Manson JE, Anderson G, Huang AJ, Vittinghoff E, Lee JS, Lacroix AZ, Cauley JA, Jackson R, Grady D, Lane DS, Phillips L, Simon MS, Cummings SR.

J Natl Cancer Inst. 2013 Oct 2;105(19):1496-503. doi: 10.1093/jnci/djt243. Epub 2013 Sep 16.

27.

Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women.

Kabat GC, Anderson ML, Heo M, Hosgood HD 3rd, Kamensky V, Bea JW, Hou L, Lane DS, Wactawski-Wende J, Manson JE, Rohan TE.

Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1353-63. doi: 10.1158/1055-9965.EPI-13-0305. Epub 2013 Jul 25.

28.

Clinical case management and navigation for colonoscopy screening in an academic medical center.

Cavanagh MF, Lane DS, Messina CR, Anderson JC.

Cancer. 2013 Aug 1;119 Suppl 15:2894-904. doi: 10.1002/cncr.28156.

29.

Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks.

Lane DS, Messina CR, Cavanagh MF, Anderson JC.

Cancer. 2013 Aug 1;119 Suppl 15:2842-8. doi: 10.1002/cncr.28160.

30.

Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.

Nadel MR, Royalty J, Shapiro JA, Joseph D, Seeff LC, Lane DS, Dwyer DM.

Cancer. 2013 Aug 1;119 Suppl 15:2834-41. doi: 10.1002/cncr.28164.

31.

Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.

Seeff LC, Royalty J, Helsel WE, Kammerer WG, Boehm JE, Dwyer DM, Howe WR Jr, Joseph D, Lane DS, Laughlin M, Leypoldt M, Marroulis SC, Mattingly CA, Nadel MR, Phillips-Angeles E, Rockwell TJ, Ryerson AB, Tangka FK.

Cancer. 2013 Aug 1;119 Suppl 15:2820-33. doi: 10.1002/cncr.28163.

32.

Response to Annweiler and Beauchet.

Rossom RC, Espeland MA, Manson JE, Dysken MW, Johnson KC, Lane DS, LeBlanc ES, Lederle FA, Masaki KH, Margolis KL.

J Am Geriatr Soc. 2013 Jun;61(6):1050-1. doi: 10.1111/jgs.12297. No abstract available.

PMID:
23772745
33.

Perceptions of risk factors for colorectal cancer and colorectal cancer risk-related behaviors among current, ex-, and nonsmokers.

Messina CR, Lane DS, Anderson JC.

J Cancer Educ. 2013 Sep;28(3):444-53. doi: 10.1007/s13187-013-0485-x.

PMID:
23749423
34.

Walking speed, physical activity, and breast cancer in postmenopausal women.

Kwan K, Chlebowski RT, McTiernan A, Rodabough RJ, La Monte MJ, Martin LW, Bell C, Lane DS, Kaplan RC, Irwin ML.

Eur J Cancer Prev. 2014 Jan;23(1):49-52. doi: 10.1097/CEJ.0b013e328361627e.

PMID:
23669264
35.

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL.

J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.

36.

Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.

Passarelli MN, Newcomb PA, LaCroix AZ, Lane DS, Ho GY, Chlebowski RT.

J Bone Miner Res. 2013 Sep;28(9):2043-8. doi: 10.1002/jbmr.1930.

37.

Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative.

Rossom RC, Espeland MA, Manson JE, Dysken MW, Johnson KC, Lane DS, LeBlanc ES, Lederle FA, Masaki KH, Margolis KL.

J Am Geriatr Soc. 2012 Dec;60(12):2197-205. doi: 10.1111/jgs.12032. Epub 2012 Nov 23.

38.

Recreational physical activity, body mass index, and survival in women with colorectal cancer.

Kuiper JG, Phipps AI, Neuhouser ML, Chlebowski RT, Thomson CA, Irwin ML, Lane DS, Wactawski-Wende J, Hou L, Jackson RD, Kampman E, Newcomb PA.

Cancer Causes Control. 2012 Dec;23(12):1939-48. doi: 10.1007/s10552-012-0071-2. Epub 2012 Oct 2.

39.

The association between NSAID use and colorectal cancer mortality: results from the women's health initiative.

Coghill AE, Phipps AI, Bavry AA, Wactawski-Wende J, Lane DS, LaCroix A, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1966-73. doi: 10.1158/1055-9965.EPI-12-0672. Epub 2012 Aug 29.

40.

Toward a positive aging phenotype for older women: observations from the women's health initiative.

Woods NF, Cochrane BB, LaCroix AZ, Seguin RA, Zaslavsky O, Liu J, Beasley JM, Brunner RL, Espeland MA, Goveas JS, Lane DS, Manson JE, Mouton CP, Robinson JG, Tinker LF.

J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1191-6. doi: 10.1093/gerona/gls117. Epub 2012 Apr 19.

41.

Body mass index and screening for colorectal cancer: gender and attitudinal factors.

Messina CR, Lane DS, Anderson JC.

Cancer Epidemiol. 2012 Aug;36(4):400-8. doi: 10.1016/j.canep.2012.02.002. Epub 2012 Mar 2.

42.

Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk.

Simon MS, Rosenberg CA, Rodabough RJ, Greenland P, Ockene I, Roy HK, Lane DS, Cauley JA, Khandekar J.

Ann Epidemiol. 2012 Jan;22(1):17-27. doi: 10.1016/j.annepidem.2011.10.006. Epub 2011 Nov 4.

43.

Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.

Gass ML, Cochrane BB, Larson JC, Manson JE, Barnabei VM, Brzyski RG, Lane DS, LaValleur J, Ockene JK, Mouton CP, Barad DH.

Menopause. 2011 Nov;18(11):1160-71. doi: 10.1097/gme.0b013e3182227ebd.

PMID:
21983008
44.

Dietary glycemic load, glycemic index, and carbohydrate and risk of breast cancer in the Women's Health Initiative.

Shikany JM, Redden DT, Neuhouser ML, Chlebowski RT, Rohan TE, Simon MS, Liu S, Lane DS, Tinker L.

Nutr Cancer. 2011;63(6):899-907. doi: 10.1080/01635581.2011.587227. Epub 2011 Jun 29.

45.

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.

Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Cochrane BB, Lane DS, Lee JS.

J Natl Cancer Inst. 2011 Apr 6;103(7):562-70. doi: 10.1093/jnci/djr031. Epub 2011 Feb 17.

46.

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.

Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL; WHI Investigators.

JAMA. 2010 Oct 20;304(15):1684-92. doi: 10.1001/jama.2010.1500.

47.

The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable.

Fletcher RH, Nadel MR, Allen JI, Dominitz JA, Faigel DO, Johnson DA, Lane DS, Lieberman D, Pope JB, Potter MB, Robin DP, Schroy PC 3rd, Smith RA.

J Gen Intern Med. 2010 Nov;25(11):1230-4. doi: 10.1007/s11606-010-1446-2. Epub 2010 Aug 12.

48.

Oral bisphosphonate use and breast cancer incidence in postmenopausal women.

Chlebowski RT, Chen Z, Cauley JA, Anderson G, Rodabough RJ, McTiernan A, Lane DS, Manson JE, Snetselaar L, Yasmeen S, O'Sullivan MJ, Safford M, Hendrix SL, Wallace RB.

J Clin Oncol. 2010 Aug 1;28(22):3582-90. doi: 10.1200/JCO.2010.28.2095. Epub 2010 Jun 21.

49.

An academic medical center model for community colorectal cancer screening: the Centers for Disease Control and Prevention demonstration program experience.

Lane DS, Cavanagh MF, Messina CR, Anderson JC.

Acad Med. 2010 Aug;85(8):1354-61. doi: 10.1097/ACM.0b013e3181df05e7.

PMID:
20453811
50.

Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.

Espeland MA, Shumaker SA, Limacher M, Rapp SR, Bevers TB, Barad DH, Coker LH, Gaussoin SA, Stefanick ML, Lane DS, Maki PM, Resnick SM.

J Womens Health (Larchmt). 2010 Mar;19(3):371-9. doi: 10.1089/jwh.2009.1605.

Supplemental Content

Support Center